Fiber fixes constipation and bloating

Fibre supplements, psyllium above all, help chronic constipation in adults. Trials have not shown that they reduce bloating. A 2022 pooled analysis of 16 randomized trials in 1,251 adults with chronic constipation found 66 percent responded to fibre against 41 percent on control, with more frequent and softer stools. The benefit was clearest with psyllium and pectin, at doses above 10 g a day, and, for how often people went, after at least 4 weeks. The same analysis found no change in bloating across the four trials that measured it, and more flatulence on fibre in the three that measured that. A 2026 analysis of 17 trials in 1,423 adults, which compared fibre types, ranked viscous soluble fibres, the kind that form a gel, ahead of other types for stool frequency, stool consistency and straining.

Two limits shape that answer. None of the placebo-controlled constipation trials that measured bloating used psyllium: they tested inulin, pectin and wheat bran. Two trials without a placebo group did measure bloating on psyllium. In one, 72 adults with chronic constipation took psyllium or a plum-derived fibre, 5 g twice a day for 4 weeks, and bloating scores fell in both groups, with more people on the plum fibre reporting less gas (53 against 25 percent). In the other, 79 adults took kiwifruit, prunes or 12 g of psyllium a day for 4 weeks, and bloating improved significantly only with kiwifruit, with side effects reported most often on psyllium. Neither can show what psyllium does to bloating compared with taking nothing. And the trials were short, mostly 2 to 8 weeks, in adults with long-standing constipation; none of those cited here studied children or pregnancy.

In irritable bowel syndrome (IBS), where bloating is a common complaint, results depend on the type of fibre. A 2026 pooled analysis of 30 placebo-controlled trials in 1,904 adults found 52 percent responded to fibre against 44 percent on control, with a larger effect for psyllium. Overall symptom scores did not differ significantly. Nine of the trials, with 625 people, measured bloating, and fibre made it neither better nor worse than control, with no single type of fibre standing out; one of the nine tested psyllium alone, for 12 weeks in 80 people. The authors note that trials of psyllium rarely measured bloating. In a primary care trial of 275 adults with IBS, 10 g of psyllium a day brought adequate relief to 57 percent in the first month against 35 percent on placebo. Wheat bran helped only in the third month, and not in the stricter analysis, and the most common reason people left the bran group early was that their symptoms got worse.

How each fibre behaves in the gut fits that split. In MRI studies, psyllium held water in the bowel: in 20 adults with chronic constipation, 7 g three times a day for 6 days increased colon volume and the water content of what was in the colon, a measure that tracked with how often they went. Fibres that gut bacteria ferment quickly, such as inulin, produce gas. In 19 adults with IBS, a single dose of inulin raised colon gas on MRI; psyllium alone did not raise breath hydrogen, and taking psyllium with the inulin brought colon gas down to a level not different from placebo.

UK national guidance for IBS reflects the same split. NICE advises clinicians to review fibre intake in IBS, adjusting and usually reducing it, to discourage insoluble fibre such as bran, and, where more fibre is advised, to use soluble fibre such as ispaghula (psyllium) or oats. It notes that people with wind and bloating may find oats and linseeds helpful. The US National Library of Medicine's consumer page on dietary fibre says fibre helps prevent constipation and that increasing it too quickly can lead to gas, bloating and cramps.

Psyllium is sold in the US as an over-the-counter laxative for occasional constipation. Its label states it generally produces a bowel movement in 12 to 72 hours and that minor bloating may occur as the body adjusts to more fibre. It warns that taken without enough fluid it can swell and block the throat or esophagus, that it is not for people who have difficulty swallowing, and that it can cause allergic reactions. It directs taking it at least 2 hours before or after other medicines because it may change how they work, and lists constipation lasting more than 7 days, rectal bleeding, or no bowel movement as reasons to stop and ask a doctor, since these may signal a serious condition. It advises asking a health professional before use in pregnancy or while breastfeeding and directs consulting a doctor for children under 6. The NIH lactation database notes psyllium is not absorbed and cannot enter breast milk.

On funding: the constipation analysis was funded by the British Dietetic Association, the IBS primary care trial by the Dutch government with the psyllium donated by Pfizer, and the MRI gas study by UK and Mexican public research councils. The 2026 IBS analysis was funded by an Australian government research grant to its lead author. The MRI constipation study was funded by Ironwood Pharmaceuticals together with the UK National Institute for Health Research, and the company shared in designing and running it. The 72-person comparison of psyllium with a plum fibre was supported by a grant from Sunsweet Growers, which makes the plum fibre, with a US National Institutes of Health grant supporting one of its authors. The funding statements of the 2026 fibre-type analysis and of the kiwifruit, prune and psyllium trial could not be read.